Skip to content

Clinical trials

Phase 1/2 Mood Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mood Disorders Phase: Phase 1/2 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20061
20151
20181
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biomind Labs Inc.1
GGZ Centraal1
Jay Fournier1
Mclean Hospital1
National Institute of Mental Health (NIMH)1
Universidade do Sul de Santa Catarina1
University of Arizona1
University of California, Los Angeles1
University of Pittsburgh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mood Disorders9
Anxiety Disorders4
Major Depressive Disorder4
Bipolar Disorder1
Depressive Disorder1
Depressive Disorder, Treatment-Resistant1
Mental Disorders1
Panic Disorder1
Personality Disorders1
Sleep Wake Disorders1

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.